Prostaglandin B(2) delivers a co-stimulatory signal leading to T cell activation.
N Cattan, D Mary, A Peleraux, B Mari, C Aussel, B Rossi
Index: Eur. Cytokine Netw. 11(2) , 293-9, (2000)
Full Text: HTML
Abstract
Most of the data accumulated to date on the immunoregulatory effects of prostaglandins (PG) on T cell activation stem from the archetypal inhibitory effect of PGE(2). In this study we provide instead, the first evidence that exogenous PGB(2), a catabolic metabolite of PGE(2), synergizes with signals delivered by T cell receptor (TCR) engagement to induce interleukin-2 (IL-2) production and IL-2 receptor (IL-2R) alpha-expression in Jurkat cells. Accordingly, PGB(2) enhances the proliferation of anti-CD3-activated peripheral blood lymphocytes (PBL). In terms of cellular signaling, we present evidence that PGB(2) activates tyrosine kinase activities and efficiently increases c-fos mRNA expression and nuclear factor-kappa B (NF-kappa B) translocation to the nucleus. Owing to these features, PGB(2) appears as a new lipid mediator capable of delivering an ancillary signal leading to T lymphocyte activation.
Related Compounds
Related Articles:
2015-08-01
[J. Lipid Res. 56 , 1419-33, (2015)]
2015-07-01
[J. Agric. Food Chem. 63 , 5957-63, (2015)]
Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.
2014-07-15
[Stem Cells Dev. 23(14) , 1582-93, (2014)]
Ca2+ mobilization with leukotriene A4 and epoxytetraenes in human neutrophils.
1990-01-15
[Biochem. Pharmacol. 39(2) , 355-65, (1990)]
1989-01-01
[Pharm. Acta Helv. 64(2) , 45-50, (1989)]